Welcome to the Brockman and Brumme HIV Research Lab web page!

Our joint laboratory team integrates molecular biology, epidemiology and computational approaches to examine questions at the interface of HIV-1 virology, immunology and pathogenesis with the ultimate goal of providing new avenues for vaccine design and strategies to eradicate viral reservoirs.

Major research foci include cytotoxic T lymphocyte (CTL) responses to HIV-1, the mechanisms (and mutational pathways) that HIV-1 uses to evade these responses, and the consequences of HIV-1 immune escape on viral fitness and protein function. Dr. Brockman is also the founder of the Canada-Sub Saharan Africa HIV/AIDS Network (CANSSA[www.canssa.org] ), whose goal is to build capacity for HIV/AIDS research in Africa.